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Summary
Turner syndrome is the complex human phenotype as-
sociated with complete or partial monosomy X. Prin-
ciple features of Turner syndrome include short stature,
ovarian failure, and a variety of other anatomic and
physiological abnormalities, such as webbed neck, lym-
phedema, cardiovascular and renal anomalies, hyper-
tension, and autoimmune thyroid disease. We studied 28
apparently nonmosaic subjects with partial deletions of
Xp, in order to map loci responsible for various com-
ponents of the Turner syndrome phenotype. Subjects
were carefully evaluated for the presence or absence of
Turner syndrome features, and their deletions were
mapped by FISH with a panel of Xp markers. Using a
statistical method to examine genotype/phenotype cor-
relations, we mapped one or more Turner syndrome
traits to a critical region in Xp11.2-p22.1. These traits
included short stature, ovarian failure, high-arched pal-
ate, and autoimmune thyroid disease. The results are
useful for genetic counseling of individuals with partial
monosomy X. Study of additional subjects should refine
the localization of Turner syndrome loci and provide a
rational basis for exploration of candidate genes.
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Introduction
Turner syndrome is the phenotype associated with com-
plete or partial monosomy X in human females. The
phenotype consists of short stature, ovarian failure, and
other variable features, such as webbed neck, aortic co-
arctation, high-arched palate, low-set ears, increased
carrying angle of the elbow (cubitus valgus), hypoplastic
nails, multiple pigmented nevi (moles), impaired glucose
tolerance, hypertension, autoimmune thyroid disease,
and other minor stigmata. The neurocognitive profile is
characterized by selective nonverbal deficits usually
without global impairment.
The pathogenesis of the Turner syndrome phenotype
is complex. Most authors believe that growth retarda-
tion, ovarian failure, and other physical abnormalities
are separate and distinct genetic effects. Growth failure
may result from deficiency of X-linked gene(s), perhaps
together with nonspecific effects of aneuploidy. Similarly,
ovarian failure may be due to inadequate dosage of X-
linked genes (Krauss et al. 1987) and/or incomplete mei-
otic-chromosome pairing (Burgoyne and Baker 1985).
Webbed neck, aortic coarctation, and hypoplastic nails
may all be secondary to in utero lymphedema (Lippe
1991). Alternatively, neural crest–cell defects may be the
etiology of cardiovascular anomalies, as well as of mul-
tiple pigmented nevi (Miyabara et al. 1989, 1997). The
pathogenesis of impaired glucose tolerance, hyperten-
sion, autoimmune thyroid disease, and cognitive deficits
is obscure.
The task of identification of specific genes responsible
for Turner syndromemay, at first glance, seemherculean,
since the X chromosome encodes probably thousands of
genes. However, there are some mitigating factors. Most
X-linked genes are subject to X inactivation during early
embryogenesis and are thus functionally haploid in both
45,X and 46,XX fetuses during critical developmental
stages (Lyon 1961). These genes are thus unlikely to be
1758 Am. J. Hum. Genet. 63:1757–1766, 1998
involved in the Turner syndrome phenotype, with the
possible exception of ovarian failure, since the inactive
X is reactivated during oogenesis. Furthermore, it ap-
pears that the Y chromosome supplies the second dose
of critical Turner syndrome genes in normal males.
Therefore, Turner syndrome genes are predicted to be
X-Y homologous and to escape X inactivation (Zinn et
al. 1993). There are presently only 18 such candidate
genes, and this number is unlikely to increase substan-
tially (Lahn and Page 1997). The challenge is to deter-
mine which of these genes, acting alone or in concert,
cause the Turner syndrome phenotype.
One way of addressing this problem is to compare the
phenotypes of individuals missing various portions of
one sex chromosome. Previous cytogenetic and molec-
ular studies suggest that most Turner syndrome physical
features map to the short arms of the X and Y chro-
mosomes (Ferguson-Smith 1965; Kalousek et al. 1979;
Fryns et al. 1981; Goldman et al. 1982; Simpson 1988;
Jacobs et al. 1990; Temtamy et al. 1992; Ogata and
Matsuo 1995). The 2.6-Mb Xp-Yp pseudoautosomal re-
gion would seem likely to play a role in Turner syn-
drome: X- and Y copies of the region are identical, and
all genes within the region appear to escape X inacti-
vation (Rappold 1993). However, short stature is the
only clinical finding consistently associated with dele-
tions of just this region (Ballabio et al. 1989; Ogata et
al. 1992a, 1992b; Ogata and Matsuo 1995).
Identification of genes or critical regions responsible
for individual Turner syndrome features other than short
stature (e.g., renal malformations, palate abnormalities,
short fourth metacarpal, strabismus, lymphedema, etc.)
has been problematic. Most studies have used only cy-
togenetic, not molecular, techniques to define X-chro-
mosome abnormalities (Ferguson-Smith 1965; Kalousek
et al. 1979; Fryns et al. 1981; Goldman et al. 1982;
Simpson 1988; Jacobs et al. 1990; Temtamy et al. 1992;
Ogata and Matsuo 1995). The precision and accuracy
of cytogenetics may not be adequate for genotype cor-
relations. Mosaicism, frequently present in Turner syn-
drome patients, may confound karyotype/phenotype as-
sociations. Literature reviews with large sample sizes are
subject to interobserver variation in phenotypic evalu-
ation. Last, the variability of Turner syndrome features,
even among 45,X patients, necessitates statistical meth-
odology for genotype/phenotype correlations.
Our goal in the current study was to improve the
phenotype mapping of Turner syndrome. To this end,
we assembled a cohort of 28 subjects with partial mono-
somy for Xp and carefully analyzed their phenotypes
and chromosome abnormalities. We also applied a quan-
titative statistical method for testing the relationships
between phenotypes and X-chromosome deletions. Our
results provide evidence for the presence of one or more
loci in Xp11.2-p22.1 that are involved in growth, ovar-
ian function, and some but not all Turner syndrome
physical abnormalities. These results provide a frame-
work for identification of candidate Turner syndrome
genes.
Subjects and Methods
Subjects
This study was approved by the human-studies com-
mittees at Thomas Jefferson University and University
of Texas Southwestern Medical School. Informed con-
sent and assent was obtained either from the participants
or, in the case of minors, from a parent or legal guardian.
Prospective subjects were identified on the basis of ab-
normal karyotypes that included partial Xp monosomy
due to either a deletion or an unbalanced translocation.
We excluded patients with any of the following: (1)
known sex-chromosome mosaicism; (2) X isochromo-
somes, because of the high likelihood of mosaicism and
the possible confounding effects of Xq and proximal Xp
duplication (Wolff et al. 1996); (3) ring X chromosomes,
since such patients are also likely to have mosaicism
because of mitotic instability of rings; and/or (4) auto-
somal aneuploidy other than unbalanced X;autosome
translocations.
Cytogenetic and Molecular Analyses
Repeat karyotypes were obtained for subjects not
evaluated cytogenetically during the preceding 2 years.
At least 20 cells were examined for mosaicism, for each
subject. A blood sample was drawn at the time of clinical
evaluation, for molecular-cytogenetic studies. Lympho-
blastoid cell lines were derived by standard methods
(Gilbert 1995). DNA prepared from 1ml of whole blood
by means of a commercial kit (Promega) was test-
ed for skewed X inactivation, by the androgen recep-
tor–methylation assay (Allen et al. 1992).
We examined metaphase spreads from cultured pe-
ripheral blood leukocytes (PBLs), for the presence of
either 45,X mosaicism or cryptic X translocations, using
FISH with an X-centromere probe (DXZ1) and a whole
X-chromosome paint. At least 50 metaphases were ex-
amined for each subject. We then mapped deletions by
FISH, using single-copy Xp probes and metaphases pre-
pared from PBLs and/or lymphoblastoid cell lines. Every
probe detected two loci in 185% of metaphases from
control 46,XX cells. Each hybridization included the
DXZ1 centromere probe as a control for random X-
chromosome loss during preparation of metaphase
spreads. A marker was scored as not deleted if two loci
were detected in most metaphases. A marker was scored
as deleted if two loci were never detected in five or more
metaphases. Hybridizations were repeated if necessary,
so that at least five metaphases were examined. In no
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case was the presence or absence of a marker on the
deleted X chromosome ambiguous. Markers were tested
sequentially until the closest loci flanking each break-
point were determined.
Phenotype Evaluation
The evaluation included a careful history and physical
examination emphasizing abnormalities associated with
Turner syndrome (webbed neck, lymphedema, increased
carrying angle, etc.), anthropometric measurements, and
appropriate laboratory tests. Twenty-two subjects were
evaluated in person by one of us (J.L.R.). Two subjects
(SW16 and SW105) were each seen by two geneticists.
Four subjects (SW46, SW144, SW145, and SW146)
were reported to have no Turner syndrome stigmata.
Since we did not personally evaluate these four subjects,
we did not include their palate or carrying-angle phe-
notypes in the statistical analyses.
Heights were measured with a stadiometer. Measured
or reported parental heights were also recorded. Mid–
parental height adjusted for the child’s sex (i.e., target
height) was calculated by the formula 0.5 # [father’s
height (cm) 13  mother’s height (cm)] (Tanner et al.
1970). In seven cases, the deletion was also present in
the subject’s mother. For these subjects we substituted
the mothers’ target height (based onmid–parental height
of maternal grandparents) for her measured or reported
height. Target height LOD score (Z) values were cal-
culated from sex-adjusted mid–parental-height data ob-
tained from the National Center for Health Statistics’
growth-curve data (Hamill et al. 1979). Mid–parental
height was not calculated for one subject, who was
adopted.
Cardiac anomalies were documented by ultrasound.
Renal anomalies were documented by ultrasound or IVP.
Metacarpals were inspected radiographically. The di-
agnosis of ovarian failure was based on measurements
of serum estradiol, follicle-stimulating hormone (FSH),
and luteinizing hormone (LH) levels. Ovarian failure
was defined by castrate levels of FSH and LH for subjects
10 years of age. Ovarian function in girls !10 years
of age was considered indeterminate, and their gonad-
otropin measurements were repeated periodically during
the course of the study.
Webbed neck included redundant skin. Since lym-
phedema can resolve over time, this feature was consid-
ered positive either if it was present on exam or if a
history of lymphedema was documented in medical rec-
ords. Palate abnormalities were noted by inspection and
included an inverted U shape or an “ogival” form char-
acterized by a narrow vault with bulging of the lateral
alveolar ridges. Subjects were photographedwith elbows
maximally extended and supinated, to measure carrying
angle. Miscellaneous Turner syndrome features (strabis-
mus, multiple pigmented nevi, congenitally dislocated
hips or scoliosis, and abnormal nails) were clinically as-
sessed. Thyroid abnormalities were documented bymea-
surement of serum thyroxine (T4) and thyroid-stimu-
lating hormone levels, as well as by thyroid-antibody
titers.
Statistical Analysis
Our approach to phenotype mapping of Turner syn-
drome, a chromosome disorder, was analogous to
association studies for Mendelian or complex traits
(Lander and Schork 1994). We analyzed subjects’ de-
letions with a set of markers distributed along the short
arm of the X chromosome. For each marker, we divided
subjects into two groups: those with or without deletion
of that marker. Each trait was considered as either a
dichotomous variable (e.g., ovarian failure [yes or no])
or a numerically continuous variable (e.g., height).
Dichotomous variables.—For each marker, we com-
pared the proportion of individuals with a given trait,
in the group with the marker deleted, versus the pro-
portion of individuals with the same trait, in the group
without the marker deleted. The comparison between
the proportions was based on a simple Z value for the
difference of two binomial proportions. We did not use
Yates’s correction for continuity, which is often sug-
gested for binomial probabilities with small sample sizes
(expected frequencies less than five), in order to avoid
missing associations.
Numerically continuous variables.—We used an un-
paired t-test to compare the mean of all individuals with
the marker deleted versus the mean of all individuals
without the marker deleted, for each marker. The
strength of the association was estimated from the Z
value t score. The P value associated with a specific test
would be appropriate for testing one specific marker.
However, we tested a series of markers. Thus, the proper
P value is actually the observed P value times the number
of markers tested. Furthermore, because we analyzed
multiple traits, we applied an additional Bonferroni cor-
rection for simultaneous multiple inferences. Therefore,
the P value that we reported for a specific marker (of a
set of m markers) and a specific trait (of a set of k traits)
equals the observed P value times mk. For our tests (one
tailed) at , comparing six markers and five traits,a  .05
the threshold required for an observed P value to be
considered statistically significant was P ! .0017
( ; ).Z  2.93 t  3.2.0017 .0017,25
Results
Subjects
Subjects who participated in this study are listed in
table 1, along with karyotype results from clinical rec-
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Table 1
Reported Karyotypes and Chronological Ages of Subjects at the
Time of Evaluation
Subject Karyotype
Age
(years)
SW16 46,X,der(X)t(X;1)(p11;q44)mat 17.4
SW46 46,X,del(X)(p21) 33.7
SW71 46,X,del(X)(p11.2) 20.2
SW74 46,X,del(X)(p11.21) 13.2
SW75 46,X,del(X)(p11.3) 12.6
SW80 46,X,del(X)(p11.4) 13.0
SW85 46,X,del(X)(p11.2) 45.2
SW86 46,X,der(X)t(X;X)(p11;q24) 10.7
SW92 46,X,del(X)(p11.23) 4.5
SW93 46,X,del(X)(p11.23) 10.1
SW96 46,X,del(X)(p21.2) 12.9
SW97 46,X,del(X)(p21.2) 12.9
SW103 46,X,del(X)(p11.2) 1.3
SW105 46,X,der(X)t(X;1)(p11;q44)mat 25.4
SW106 46,X,del(X)(p22.3) 7.0
SW109 46,X,del(X)(p11.1) 45.9
SW111 46,X,del(X)(p11.21) 15.2
SW112 46,X,del(X)(p11.2) 10.7
SW122 46,X,del(X)(p21.2) 16.2
SW144 46,X,del(X)(p22.12p22.33) 35.8
SW145 46,X,del(X)(p22.12p22.33)mat 14.2
SW146 46,X,del(X)(p22.12p22.33)mat 12
SW151 46,X,del(X)(p11.2) 7
SW157 46,X,del(X)(p22.31p22.33) 41.5
SW161 46,X,del(X)(p11.23) 8.6
SW174 46,X,der(X)t(X;A)(p22.3;p11.2)mata 21.9
SW175 46,X,der(X)t(X;A)(p22.3;p11.2)a 39.7
SW190 46,(X),del(X)(p22.1) 40
a A  acrocentric chromosome positive for NOR staining and beta
satellite but not alpha satellite sequences by FISH.
Table 2
Molecular-Cytogenetic Markers
Locusa
Positionb
(Mb) Band Probe Source
DXYS14 0 Xp22.33 c11D2 G. Rappold
DXS7470 9 Xp22.32 b9P2 Research Genetics
PDHA1 20 Xp22.13 cPDH3 H. Dahl
DXS274 23 Xp22.13 ICRFc104A0359 RLDB (Zehetner and Lehrach 1994)
GK 33 Xp21.3 ICRFc104E07137 RLDB
DXS1110 40 Xp11.4-p21.1 b227D11 Research Genetics
SYN1 47 Xp11.3 cSY11 T. Su¨dhof
SYP 50 Xp11.23 c38-10 T. Su¨dhof
DXS423E 54 Xp11.22 ICRFc100H0164 RLDB
ZXDB 58 Xp11.21 ICRFc104A07135 RLDB
DXZ1 60 Xcen pBAMX7 H. Willard
a Data from markers that are underlined were used for statistical analyses.
b From the Sixth International Workshop on X Chromosome Mapping (Nelson et al. 1995).
ords and chronological age at the time of evaluation for
this study. Subjects were Caucasian (23), African Amer-
ican (2), Hispanic (2), and Asian (1) and had an age
range of 1.3–45.2 years. SW16/105, SW96/97, and
SW145/146 were sib pairs. SW144 was the mother of
SW145 and SW146; SW175 was the mother of SW174.
Other subjects were unrelated.
Molecular Cytogenetics
Markers spaced at ∼10-Mb intervals along the 60-Mb
X-chromosome short arm (table 2) were tested initially.
Additional markers were then tested to resolve clustered
breakpoints but were not included in statistical analyses.
DXYS14, situated !100 kb from theXp/Yp subtelomeric
repeats, distinguished terminal versus interstitial dele-
tions.
The molecular-cytogenetic breakpoints are depicted
graphically in figure 1. Karyotypes were generally ac-
curate. We did find that subjects SW144, SW145, and
SW146 had either a terminal Xp deletion or a cryptic
X translocation, rather than an interstitial Xp deletion.
Conversely, subject SW190 had an interstitial Xp dele-
tion that was thought, on the basis of karyotyping, to
be terminal. The largest group of breakpoints clustered
within a few megabases of the X centromere. We were
able to resolve several cytogenetically similar break-
points by using molecular markers. For example, the
Xp11.2 breakpoints of SW71, SW85, and SW103 could
be distinguished by our FISH probes.
The X-inactivation pattern in peripheral blood leu-
kocytes from 21 subjects was also examined, by means
of the androgen-receptor gene–methylation assay (see
Subjects andMethods). This assay measures the presence
of methylated cytosine residues flanking a highly poly-
morphic trinucleotide repeat in the X-linked androgen-
receptor gene. The presence of methylation reflects in-
activation of an androgen-receptor allele and its chro-
mosome. Twenty subjects were informative for the an-
drogen-receptor polymorphism. Of these 20, 18 showed
completely skewed inactivation, with evidence for meth-
ylation of only one androgen-receptor allele (presumably
the allele borne by the deleted X chromosome, because
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Figure 1 Graphic representation of deletions. Bars represent material present in deleted X chromosomes. Positions ofmolecular-cytogenetic
markers are indicated.
of selection against cells in which the normal X is in-
activated [Migeon 1998]) (data not shown). The two
subjects without complete skewing, SW174 and SW175,
had a very small deletion.
Phenotype Mapping
Table 3 shows the presence or absence in our subjects
of five Turner syndrome–associated phenotypes: short
stature, high-arched palate, increased carrying angle,
thyroid antibodies, and ovarian failure. All subjects were
evaluated as described in Subjects and Methods. In gen-
eral, but not always, the phenotype was similar in rel-
atives with the identical deletion. For example, ovarian
failure was apparently absent in SW97 and was present
in her sister, SW96. Siblings SW16 and SW105 were
discordant for thyroid autoimmunity and the presence
of a high-arched palate. Phenotypic features that we did
not personally evaluate or that were not objectively doc-
umented in medical records were not scored. Missing
data were not used in statistical analyses.
Certain Turner syndrome–associated abnormalities
were present in so few subjects that we did not attempt
statistical analysis of the loci involved. These included
horseshoe kidney (1 subject), aortic coarctation (0),
webbed neck (0), and lymphedema (2). Other minor
Turner syndrome stigmata, including multiple pig-
mented nevi, short 4th or 5th metacarpal, abnormal
nails, strabismus, congenitally dislocated hips, and sco-
liosis, were seen in a number of subjects but showed no
apparent relationship to the size or position of deletions
(data not shown). We focused our statistical analysis on
the following five phenotypic traits: short stature, high-
arched palate, increased carrying angle, thyroid anti-
bodies, and ovarian failure.
We tested the association between these traits and the
presence or absence of specified Xp markers (DXYS14,
DXS7470, PDHA1, GK, DXS1110, and SYP) that are
spaced at ∼10-Mb intervals (Nelson et al. 1995). Table
4 shows the results for stature (adjusted formid–parental
or target height). No comparison was made for the most
distal marker (DXYS14), since only one subject did not
have this marker deleted. Subjects with deletion of
DXS7470 or PDHA1 tended to have lower mean heights
than were seen in subjects not deleted for these markers,
although the differences were not statistically significant.
By contrast, the mean stature of subjects deleted for GK
was almost 2 SDs less than that of subjects not deleted
for this marker. This difference was statistically signifi-
cant. No breakpoints fell between GK and DXS1110,
so the statistical results for these two markers were iden-
tical. The decrease in mean stature SDs that was asso-
ciated with deletion of SYP, although still statistically
significant, was less than that associated with deletion
of GK/DXS1110.
We performed similar analyses for ovarian failure, ab-
normal palate, and autoimmune thyroid disease. In these
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Table 3
Phenotypic Data
Subject
SD from
Mid–Parental
Heighta Palateb
Carrying
Angleb Thyroid Antibodies
Ovarian
Failure?a
SW75 2.2 High arched Markedly increased Absent No
SW74 3.3 High arched Mildly increased Present No
SW93 3.5 High arched Mildly increased Present Yes
SW97 .4 High arched Mildly increased Absent No
SW86 1.2 High arched Mildly increased Absent Yes
SW106 1.6 Normal Markedly increased Absent ND
SW96 1.2 Normal Mildly increased Absent Yes
SW109 4.7 High arched Mildly increased Absent Yes
SW175 1.82 Normal Mildly increased Absent No
SW174 .8 Normal Normal Absent No
SW161 3.3 High arched Mildly increased Present ND
SW111 3.3 High arched Mildly increased Present Yes
SW112 3.9 Ogival Mildly increased Present Yes
SW46 .3 (Normal) (Normal) Absent No
SW85 3.4 Ogival Mildly increased Absent Yes
SW122 2.7 Normal Mildly increased Absent Yes
SW151 2.5 High arched Normal Present ND
SW103 2.7 Ogival Mildly increased Absent Yes
SW146 .4 (Normal) (Normal) Absent No
SW144 .6 (Normal) (Normal) Absent No
SW145 1.4 (Normal) (Normal) Absent No
SW71 2 Normal Markedly increased Absent Yes
SW157 .9 Normal Mildly increased Absent No
SW190 .8 Normal Mildly increased Absent No
SW105 3.3 Normal Normal Present Yes
SW16 3.5 High arched Normal Absent Yes
SW92 2.4 Ogival Mildly increased Present Yes
SW80 ND High arched Markedly increased Present Yes
a ND  not determined (see text).
b Phenotypes in parentheses were by report only and were not used in statistical analyses.
cases, the phenotypes were considered as dichotomous
variables. The results are shown in tables 5–7. There
was statistically significant evidence for a locus or loci
for gonadal dysgenesis and abnormal palate in the same
interval spanning GK–DXS1110. The data also indicate
a possible locus for autoimmune thyroid disease within
the same interval, although the strength of this associ-
ation did not achieve statistical significance. By contrast,
we did not find any association between increased car-
rying angle and deletion of anymarker (data not shown).
Figure 2 shows a graphic summary of the associations
between these five traits and the presence or absence of
the six markers.
Discussion
Our key finding is that a locus (or loci) for short stat-
ure, ovarian failure, and high-arched palate maps to one
region of the X chromosome, Xp11.2-p22.1. Our data
also suggest a possible locus for autoimmune thyroid
disease in this same region, although this result was not
statistically significant. The critical region comprises ap-
proximately one-fifth of the X chromosome and is con-
sistent with previous inferences from karyotype/pheno-
type correlations (Ferguson-Smith 1965; Fraccaro et al.
1977; Kalousek et al. 1979; Fryns et al. 1981; Goldman
et al. 1982; Simpson 1988; Jacobs et al. 1990; Massa
et al. 1992; Temtamy et al. 1992; Ogata and Matsuo
1995).
Our data suggest that a stature determinant is situated
between markers PDHA1 (Xp22.1) and SYP (Xp11.2).
Weaker associations between stature and deletion of
markers that are more distal (e.g., DXS7470) or more
proximal (e.g., SYP) can be explained by the fact that
deletions were contiguous and spanned more than one
interval. For example, all subjects missing SYP were also
missing the markers, GK/DXS1110, that were maxi-
mally associated with short stature. Conversely, not
every subject missing GK/DXS1110 was also missing
SYP. Those subjects missing GK/DXS1110 but not SYP
would weaken the association between stature and SYP.
A more distal short-stature gene, SHOX, has recently
been identified in the Xp-Yp pseudoautosomal region
(Rao et al. 1997). Only one of our subjects was not
deleted for the pseudoautosomal region, and she had
normal stature. FISH with a cosmid probe (not shown)
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Table 4
Mean  SD Z-Score for Mid–Parental Height or Target Height
MARKER POSITION
MEAN  SD Z-SCORE FOR
PARENT-ADJUSTED HEIGHT (n), FOR
DIFFERENCE
IN MEANS t df
Deleted
Marker
Marker
Not Deleted
DXYS14 0 2.20  1.25 (26) .80  .00 (1) 3.00 )
DXS7470 9 2.21  1.38 (24) 1.17  .55 (3) 1.04 1.27 25
PDHA1 20 2.23  1.41 (23) 1.28  .50 (4) .96 1.33 25
GK 33 3.01  .86 (15) .94  .89 (12) 2.07 6.13 25
DXS1110 40 3.01  .86 (15) .94  .89 (12) 2.07 6.13 25
SYP 50 3.51  .58 (8) 1.49  1.11 (19) 2.02 4.82 25
Table 5
Ovarian-Failure Trait
MARKER POSITION
NO. WITH TRAIT/NO.
WITHOUT TRAIT, FOR
DELTA
PROPORTION Z
Deleted
Marker
Marker
Not Deleted
DXYS14 0 14/10 0/1 .583 .123
DXS7470 9 14/8 0/3 .636 1.463
PDHA1 20 14/8 0/3 .636 1.463
GK 33 12/2 2/9 .675 2.971
DXS1110 40 12/2 2/9 .675 2.971
SYP 50 8/1 6/10 .514 2.065
confirmed the presence of two copies of SHOX in this
subject. By comparison, the mean height SDs of subjects
missing DXYS14 (SHOX) was 2.2.
Interestingly, the association of short stature and de-
letion of Xp22.1-p11.2 was not statistically significant
when stature was not adjusted for mid–parental height
(data not shown). Other studies have shown that cor-
relation with mid–parental height is preserved in Turner
syndrome (Brook et al. 1977). Thus, this haploinsuffi-
cient effect of Xp loci can be modified by genetic back-
ground. Subjects with the largest Xp deletions had height
deficits essentially equivalent to that typically seen in
45,X Turner syndrome, suggesting that Xq loci play little
or no role in growth failure. However, most of our sub-
jects were ascertained because of short stature, and
therefore the effect of Xp deletions on stature may be
overestimated.
Data from previous studies indicate that ovarian fail-
ure is frequent in women with deletions of either Xp or
Xq. Some have interpreted this finding to imply that the
primary Turner syndrome ovarian defect involves mei-
otic-chromosome pairing (Ogata and Matsuo 1995). To
the contrary, autopsy studies have indicated that germ
cells are deficient in 45,X fetuses even prior to the pach-
ytene stage, when chromosomes pair (Speed 1986). Our
data suggest a phenotypic difference between distal de-
letions, associated with preserved ovarian function, and
proximal deletions, associated with ovarian failure. The
correlation is imperfect, since at least one subjectmissing
almost all of Xp still had functioning ovaries. Until long-
term follow-up studies have been conducted, we cannot
rule out the possibility that our subjects with preserved
ovarian function will suffer premature menopause. An-
other limitation of our data is that ovarian failure, de-
fined as castrate levels of gonadotropins, cannot be re-
liably determined in young children, such as were three
of our subjects.
One candidate gene within the critical region for ovar-
ian failure is ZFX, which maps to Xp21.2. ZFX encodes
a transcription factor of unknown function (Page et al.
1987); inactivation of the orthologous gene in mice
causes growth retardation and reduced germ-cell num-
ber (Luoh et al. 1997). The hypothesis that ZFX hap-
loinsufficiency contributes to ovarian failure could be
tested by mutational analysis of 46,XX women with
premature ovarian failure.
The localization of a high arched–palate determinant
to Xp11.2-p22.1 was unexpected. High-arched palate,
seen in many chromosome disorders, is generally con-
sidered a nonspecific aneuploidy effect. It may be that
haploinsufficiency of one or a few genes is the major
etiologic factor for high-arched palate associated with
Turner syndrome, as appears to be the case for short
stature. By contrast, there does not appear to be a major
Xp locus for increased carrying angle of the elbow. The
absence of a locus for cubitus valgus was surprising,
since this classic trait is a relatively specific feature of
monosomy X. It is possible that a gene(s) outside the
critical region—for example, SHOX—contributes to this
trait. Our finding that some Turner syndrome traits were
associated with deletion of the critical region whereas
others were not argues that the associations were not
due to occult 45,X mosaicism.
Autoimmune thyroid disease is present in approxi-
mately one-third of our 45,X Turner syndrome patients
(J. L. Ross, unpublished observation). This phenotype
may be difficult to assess, because antibodies tend to
develop with increasing age, and different antibodies
(peroxidase, microsomal, or thyroglobulin) are mea-
sured by various laboratories. Our data suggest that hap-
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Table 6
High Arched–Palate Trait
MARKER POSITION
NO. WITH TRAIT/NO.
WITHOUT TRAIT, FOR
DELTA
PROPORTION Z
Deleted
Marker
Marker
Not Deleted
DXYS14 0 15/8 0/1 .652 .264
DXS7470 9 15/6 0/3 .714 1.753
PDHA1 20 15/5 0/4 .750 2.263
GK 33 14/2 1/7 .750 3.130
DXS1110 40 14/2 1/7 .750 3.130
SYP 50 8/1 7/8 .422 1.633
Table 7
Autoimmune Thyroid–Disease Trait
MARKER POSITION
NO. WITH TRAIT/NO.
WITHOUT TRAIT, FOR
DELTA
PROPORTION Z
Deleted
Marker
Marker
Not Deleted
DXYS14 0 9/18 0/1 .333 .389
DXS7470 9 9/16 0/3 .360 .607
PDHA1 20 9/15 0/4 .375 .909
GK 33 9/7 0/12 .563 2.745
DXS1110 40 9/7 0/12 .563 2.745
SYP 50 5/4 4/ 15 .345 1.393
loinsufficiency of a locus in Xp11.2-p22.1, perhaps the
same locus as that causing growth retardation, ovarian
failure, or high-arched palate, also contributes to im-
mune dysregulation. One speculative hypothesis is that
these features are all manifestations of selective impair-
ment of cellular growth during development.
Other typical Turner syndrome features, such as aortic
coarctation or webbed neck, that are relatively common
in 45,X patients were notably absent from our subjects.
Lymphedema has been reported in 60% of 45,X new-
borns but in only 10% of Turner syndrome patients with
other karyotypes (Sybert 1995). In our series, only one
subject each had lymphedema or horseshoe kidney. One
reason for the paucity of these features could be that
deletion of Xq is required for their complete expression.
We considered the possibility that imprinting or X
inactivation might play a role in the phenotypic varia-
bility of our subjects. Imprinting could confound ap-
parent relationships between deletions and phenotypes,
unless the parental origins of the deleted chromosomes
were factored into analyses. However, several previous
reports, including a recent study describing a putative
imprinted Turner syndrome cognitive locus (Skuse et al.
1997), indicate that imprinting plays no role in Turner
syndrome physical features (Mathur et al. 1991). In
other studies, we also failed to find any phenotypic dif-
ferences due to parent-of-origin effects in 30 45,X sub-
jects (J.L. Ross, H. Kushner, A.R. Zinn, unpublished
data). Therefore, imprinting is unlikely to be important
in the present study of Turner syndrome physical fea-
tures. X-inactivation differences are also unlikely to have
contributed to phenotypic variability of our subjects. All
subjects tested, except for two with very small deletions,
showed completely skewed inactivation, as is the general
rule for partial monosomy X (Belmont 1996). The de-
letions in these two related women are 5–9 Mb in size
(B. Franco, personal communication), which is consis-
tent with inferential data from clinical manifestations of
X-linked disorders in female carriers, which suggest that
terminal Xp deletions ∼15 Mb in size do not cause
highly skewed X inactivation (Schaefer et al. 1993).
We approached phenotype mapping of Turner syn-
drome with the hypothesis that at least some features
are due to haploinsufficiency of discrete loci on the X
chromosome (Epstein 1988). Although this approach
had been tried previously, earlier studies lacked precise
phenotype descriptions, accurate molecular-cytogenetic
definition of deletions, and sufficient numbers of subjects
to permit statistical analysis. In our study, we attempted
to address each of these shortcomings. One limitation
to our data is that breakpoints were not uniformly dis-
tributed: 8 of 28 subjects were missing 180% of Xp.
This distribution may reflect clinical ascertainment
through the presence of major Turner syndrome features,
which are more likely with larger deletions. Alterna-
tively, there could be a propensity for the X chromosome
to break near the centromere, because of repetitive se-
quences or other chromatin features.
Because of the difficulties in data collection, our sta-
tistical analysis also has limitations. First, the number
of subjects in each comparison (deleted and undeleted)
is small. Second, since some of our subjects are related,
the statistical independence assumption underlying the
t and binomial-comparisons tests does not hold. How-
ever, we did not eliminate redundant or minimally
informative markers—for example, 6K/DXS1110 or
DXYS14—so our correction for multiple inferences was
conservative. As more subjects become available, wewill
not have to include related individuals, and the power
to detect phenotypic differences between groups thereby
will be increased.
Our data should be helpful for genetic-counseling in
cases of partial monosomy X, heretofore a prognostic
quandary. The results also provide the basis for future
investigations aimed at molecular identification of
Turner syndrome genes. The availability of additional
subjects should allow us to refine the map location of
Xp genes associated with specific traits and to determine
whether the associations are manifestations of haploin-
sufficiency for a single gene or gene cluster. Guided by
this information, mutational analysis of karyotypically
normal individuals with Turner syndrome traits may re-
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Figure 2 Strength of associations between deleted markers and
five phenotypic traits: adjusted height, ovarian failure (ovary), high-
arched palate (palate), thyroid autoantibodies (thyroid), and increased
carrying angle of the elbow (carrying angle). A score of “0” indicates
that there is no association. Scores 1∼3 are statistically significant (see
Subjects and Methods).
veal the culprit genes. The statistical approach that we
have used should be useful for phenotype mapping not
only of Turner syndrome but also of other aneuploidy
syndromes, such as trisomy 21, for which accurate mo-
lecular-cytogenetic and phenotypic data are available
(Epstein et al. 1991; Korenberg et al. 1994).
Acknowledgments
This work was supported by National Institutes of Health
grant R01 NS35554. We thank Bing Ouyang and Lillian Sellati
for performing molecular-cytogenetic analyses, Dr. Gudrun
Rappold for the SHOX probe, Dr. Nancy Schneider and Debra
Cohen for karyotyping, and Karen Kowal for assistance with
phenotype evaluations. We especially thank the many physi-
cians who referred patients for this study, especially Drs. G.
S. Pai, Murray Finegold, and Anzer Haidar, and we thank Dr.
David Page for calling our attention to several subjects.
References
Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont
JW (1992) Methylation of HpaII and HhaI sites near the
polymorphic CAG repeat in the human androgen-receptor
gene correlates with X chromosome inactivation. Am JHum
Genet 51:1229–1239
Ballabio A, Bardoni B, Carrozzo R, Andria G, Bick D, Camp-
bell L, Hamel B, et al (1989) Contiguous gene syndromes
due to deletions in the distal short arm of the human X
chromosome. Proc Natl Acad Sci USA 86:10001–10005
Belmont JW (1996) Genetic control of X inactivation and pro-
cesses leading to X-inactivation skewing. Am J Hum Genet
58:1101–1108
Brook CG, Gasser T, Werder EA, Prader A, Vanderschueren-
Lodewykx MA (1977) Height correlations between parents
and mature offspring in normal subjects and in subjects with
Turner’s and Klinefelter’s and other syndromes. Ann Hum
Biol 4:17–22
Burgoyne PS, Baker TG (1985) Perinatal oocyte loss in XO
mice and its implications for the aetiology of gonadal dys-
genesis in XO women. J Reprod Fertil 75:633–645
Epstein CJ (1988) Mechanisms leading to the phenotype of
Turner syndrome. In: Rosenfeld RG, Grumbach MM (eds)
Turner syndrome. Marcel Dekker, New York, pp 13–28
Epstein CJ, Korenberg JR, Annere´n G, Antonarakis SE, Ayme´
S, Courchesne E, Epstein LB, et al (1991) Protocols to es-
tablish genotype-phenotype correlations in Down syndrome.
Am J Hum Genet 49:207–235
Ferguson-Smith MA (1965) Karyotype-phenotype correlations
in gonadal dysgenesis and their bearing on the pathogenesis
of malformations. J Med Genet 2:142–155
Fraccaro M, Maraschio P, Pasquali F, Scappaticci S (1977)
Women heterozygous for deficiency of the (p21-pter) region
of the X chromosome are fertile. Hum Genet 39:283–292
Fryns JP, Petit P, Van den Berghe H (1981) The various phe-
notypes in Xp deletion: observations in eleven patients.Hum
Genet 57:385–387
Gilbert J (1995) Establishment of permanent cell lines by Ep-
stein-Barr virus transformation. In: Dracopoli N, Haines J,
Korf B, Moir D, Morton C, Seidman C, Seidman J, et al
(eds) Current protocols in human genetics. Vol 2. John Wi-
ley, New York, pp A.3.H.1–A.3.H.5
Goldman B, Polani PE, Daker MG, Angell RR (1982) Clinical
and cytogenetic aspects of X-chromosome deletions. Clin
Genet 21:36–52
Hamill PVV, Drizd TA, Johnson CL, Reed RB, Roche AF,
Moore WM (1979) Physical growth: National Center for
Health Statistics percentiles. Am J Clin Nutr 32:607–629
Jacobs PA, Betts PR, Cockwell AE, Crolla JA, Mackenzie MJ,
Robinson DO, Youings SA (1990) A cytogenetic and mo-
lecular reappraisal of a series of patients with Turner’s syn-
drome. Ann Hum Genet 54:209–223
Kalousek D, Schiffrin A, Berguer AM, Spier P, Guyda H, Colle
E (1979) Partial short arm deletions of the X chromosome
and spontaneous pubertal development in girls with short
stature. J Pediatr 94:891–894
Korenberg JR, Chen XN, Schipper R, Sun Z, Gonsky R, Ger-
wehr S, Carpenter N, et al (1994) Down syndrome phe-
notypes: the consequences of chromosomal imbalance. Proc
Natl Acad Sci USA 91:4997–5001
Krauss CM, Turksoy RN, Atkins L, McLaughlin C, Brown
LG, Page DC (1987) Familial premature ovarian failure due
to an interstitial deletion of the long arm of the X chro-
mosome. N Engl J Med 317:125–131
Lahn BT, Page DC (1997) Functional coherence of the human
Y chromosome. Science 278:675–680
Lander ES, Schork NJ (1994) Genetic dissection of complex
traits. Science 265:2037–2048
Lippe B (1991) Turner syndrome. Endocrinol Metab Clin
North Am 20:121–152
Luoh SW, Bain PA, Polakiewicz RD, Goodheart ML, Gardner
1766 Am. J. Hum. Genet. 63:1757–1766, 1998
H, Jaenisch R, Page DC (1997) Zfx mutation results in small
animal size and reduced germ cell number in male and fe-
male mice. Development 124:2275–2284
Lyon MF (1961) Gene action in the X-chromosome of the
mouse (Mus musculus L.). Nature 190:372–373
Massa G, Vanderschueren-Lodeweyckx M, Fryns JP (1992)
Deletion of the short arm of the X chromosome: a hereditary
form of Turner syndrome. Eur J Pediatr 151:893–894
Mathur A, Stekol L, Schatz D, MacLaren NK, ScottML, Lippe
B (1991) The parental origin of the single X chromosome
in Turner syndrome: lack of correlation with parental age
or clinical phenotype. Am J Hum Genet 48:682–686
Migeon BR (1998) Non-random X chromosome inactivation
in mammalian cells. Cytogenet Cell Genet 80:142–148
Miyabara S, Nakayama M, Suzumori K, Yonemitsu N, Su-
gihara H (1997) Developmental analysis of cardiovascular
system of 45,X fetuses with cystic hygroma. Am J Med Ge-
net 68:135–141
Miyabara S, Sugihara H, Maehara N, Shouno H, Tasaki H,
Yoshida K, Saito N, et al (1989) Significance of cardiovas-
cular malformations in cystic hygroma: a new interpretation
of the pathogenesis. Am J Med Genet 34:489–501
Nelson DL, Ballabio A, Cremers F, Monaco AP, Schlessinger
D (1995) Report of the Sixth International Workshop on X
Chromosome Mapping 1995. Cytogenet Cell Genet 71:
308–336
Ogata T, Goodfellow P, Petit C, Aya M, Matsuo N (1992)
Short stature in a girl with a terminal Xp deletion distal to
DXYS15: localisation of a growth gene(s) in the pseudoau-
tosomal region. J Med Genet 29:455–459
Ogata T, Matsuo N (1995) Turner syndrome and female sex
chromosome aberrations: deduction of the principal factors
involved in the development of clinical features. Hum Genet
95:607–629
Ogata T, Petit C, Rappold G, Matsuo N, Matsumoto T, Good-
fellow P (1992) Chromosomal localisation of a pseudoau-
tosomal growth gene(s). J Med Genet 29:624–628
Page DC, Mosher R, Simpson EM, Fisher EM, Mardon G,
Pollack J, McGillivray B, et al (1987) The sex-determining
region of the human Y chromosome encodes a finger protein.
Cell 51:1091–1104
Rao E, Weiss B, Fukami M, Rump A, Niesler B, Mertz A,
Muroya K, et al (1997) Pseudoautosomal deletions encom-
passing a novel homeobox gene cause growth failure in id-
iopathic short stature and Turner syndrome. Nat Genet 16:
54–63
Rappold GA (1993) The pseudoautosomal regions of the hu-
man sex chromosomes. Hum Genet 92:315–324
Schaefer L, Ferrero GB, Grillo A, BassiMT, Roth EJ,Wapenaar
MC, van Ommen GJ, et al (1993) A high resolution deletion
map of human chromosome Xp22. Nat Genet 4:272–279
Simpson JL (1988) Localizing ovarian determinants through
phenotypic-karyotypic deductions. In: Rosenfeld RG,
Grumbach MM (eds) Turner syndrome. Marcel Dekker,
New York, pp 65–77
Skuse DH, James RS, Bishop DV, Coppin B, Dalton P, Aamodt-
Leeper G, Bacarese-Hamilton M, et al (1997) Evidence from
Turner’s syndrome of an imprinted X-linked locus affecting
cognitive function. Nature 387:705–708
Speed RM (1986) Oocyte development in XO foetuses of man
and mouse: the possible role of heterologous X-chromosome
pairing in germ cell survival. Chromosoma 94:115–124
Sybert V (1995) The adult patient with Turner syndrome. In:
Albertsson-Wikland K, Ranke M (eds) Turner syndrome in
a life span perspective: research and clinical aspects. Elsevier,
Amsterdam, pp 205–218
Tanner J, Goldstein H, Whitehouse R (1970) Standards for
children’s height at ages 2–9 years allowing for height of
parents. Arch Dis Child 45:755–762
Temtamy SA, Ghali I, Salam MA, Hussein FH, Ezz EH, Salah
N (1992) Karyotype/phenotype correlation in females with
short stature. Clin Genet 41:147–151
Wolff DJ, Miller AP, Van Dyke DL, Schwartz S, Willard HF
(1996) Molecular definition of breakpoints associated with
human Xq isochromosomes: implications for mechanisms
of formation. Am J Hum Genet 58:154–160
Zehetner G, Lehrach H (1994) The Reference Library Sys-
tem—sharing biological material and experimental data.
Nature 367:489–491
Zinn AR, Page DC, Fisher EMC (1993) Turner syndrome—the
case of the missing sex chromosome. Trends Genet 9:90–93
